Champions Oncology Ownership 2024 | Who Owns Champions Oncology Now?
Institutional Ownership
7.03%
Insider Ownership
25.55%
Retail Ownership
67.42%
Institutional Holders
9.00
Champions Oncology Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BATTERY MANAGEMENT CORP. | 17.81% | 3.29% | 2,421,673 | - | - | 12,520,049 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 12.61% | 0.67% | 1,713,720 | - | - | 8,859,932 | Jun 30, 2024 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 5.04% | 0.06% | 684,628 | - | - | 3,539,527 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.26% | - | 307,002 | 221,398 | 258.63% | 1,587,201 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.90% | 0.00% | 122,591 | -2,100 | -1.68% | 633,795 | Jun 30, 2024 |
| BLACKROCK INC. | 0.85% | - | 116,072 | 389 | 0.34% | 600,093 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.51% | 0.00% | 69,304 | 3 | 0.00% | 358,302 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.46% | - | 63,086 | 972 | 1.56% | 326,235 | Jun 30, 2024 |
| MORGAN STANLEY | 0.32% | - | 43,100 | 2,400 | 5.90% | 222,827 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.30% | - | 40,463 | -2,226 | -5.21% | 209,193,000 | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.25% | 0.00% | 34,308 | - | - | 178,000 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.23% | 0.00% | 30,697 | - | - | 157,000 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.20% | - | 26,749 | - | - | 138,293 | Jun 30, 2024 |
| STATE STREET CORP | 0.20% | - | 26,553 | - | - | 137,279,000 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.19% | - | 25,273 | -553 | -2.14% | 130,661 | Jun 30, 2024 |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 0.09% | 0.00% | 12,252 | - | - | 63,000 | Jun 30, 2024 |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT, INC. | 0.09% | 0.00% | 12,000 | -380 | -3.07% | 62,040 | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | 0.08% | 0.00% | 10,942 | -250 | -2.23% | 56,573 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.02% | - | 3,004 | 1,407 | 88.10% | 15,000 | Jun 30, 2024 |
| UBS GROUP AG | 0.00% | - | 379 | -728 | -65.76% | 1,959 | Jun 30, 2024 |
Champions Oncology's largest institutional shareholder is BATTERY MANAGEMENT CORP., holding 17.81% of the company's total share outstanding, currently valued at $12.52M. The top 10 institutional shareholders own together 41.06% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BATTERY MANAGEMENT CORP. | 17.81% | 3.29% | 2,421,673 | - | - | 12,520,049 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 12.61% | 0.67% | 1,713,720 | - | - | 8,859,932 | Jun 30, 2024 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 5.04% | 0.06% | 684,628 | - | - | 3,539,527 | Jun 30, 2024 |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT, INC. | 0.09% | 0.00% | 12,000 | -380 | -3.07% | 62,040 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.90% | 0.00% | 122,591 | -2,100 | -1.68% | 633,795 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.23% | 0.00% | 30,697 | - | - | 157,000 | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.25% | 0.00% | 34,308 | - | - | 178,000 | Jun 30, 2024 |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 0.09% | 0.00% | 12,252 | - | - | 63,000 | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | 0.08% | 0.00% | 10,942 | -250 | -2.23% | 56,573 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.51% | 0.00% | 69,304 | 3 | 0.00% | 358,302 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.30% | - | 40,463 | -2,226 | -5.21% | 209,193,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.26% | - | 307,002 | 221,398 | 258.63% | 1,587,201 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.46% | - | 63,086 | 972 | 1.56% | 326,235 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.20% | - | 26,749 | - | - | 138,293 | Jun 30, 2024 |
| MORGAN STANLEY | 0.32% | - | 43,100 | 2,400 | 5.90% | 222,827 | Jun 30, 2024 |
| BLACKROCK INC. | 0.85% | - | 116,072 | 389 | 0.34% | 600,093 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.19% | - | 25,273 | -553 | -2.14% | 130,661 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.02% | - | 3,004 | 1,407 | 88.10% | 15,000 | Jun 30, 2024 |
| STATE STREET CORP | 0.20% | - | 26,553 | - | - | 137,279,000 | Jun 30, 2024 |
| UBS GROUP AG | 0.00% | - | 379 | -728 | -65.76% | 1,959 | Jun 30, 2024 |
The largest Champions Oncology shareholder by % of total assets is BATTERY MANAGEMENT CORP.. The company owns 2.42M shares of Champions Oncology (CSBR), representing 3.29% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 2.26% | - | 307,002 | 221,398 | 258.63% | 1,587,201 | Jun 30, 2024 |
| MORGAN STANLEY | 0.32% | - | 43,100 | 2,400 | 5.90% | 222,827 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.02% | - | 3,004 | 1,407 | 88.10% | 15,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.46% | - | 63,086 | 972 | 1.56% | 326,235 | Jun 30, 2024 |
| BLACKROCK INC. | 0.85% | - | 116,072 | 389 | 0.34% | 600,093 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.00% | - | 133 | 133 | 100.00% | 1,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.51% | 0.00% | 69,304 | 3 | 0.00% | 358,302 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 11 | - | - | 57 | Jun 30, 2024 |
| STATE STREET CORP | 0.20% | - | 26,553 | - | - | 137,279,000 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.20% | - | 26,749 | - | - | 138,293 | Jun 30, 2024 |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 0.09% | 0.00% | 12,252 | - | - | 63,000 | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.25% | 0.00% | 34,308 | - | - | 178,000 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.23% | 0.00% | 30,697 | - | - | 157,000 | Jun 30, 2024 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 5.04% | 0.06% | 684,628 | - | - | 3,539,527 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 12.61% | 0.67% | 1,713,720 | - | - | 8,859,932 | Jun 30, 2024 |
| BATTERY MANAGEMENT CORP. | 17.81% | 3.29% | 2,421,673 | - | - | 12,520,049 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -47 | -100.00% | - | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | 0.08% | 0.00% | 10,942 | -250 | -2.23% | 56,573 | Jun 30, 2024 |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT, INC. | 0.09% | 0.00% | 12,000 | -380 | -3.07% | 62,040 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.19% | - | 25,273 | -553 | -2.14% | 130,661 | Jun 30, 2024 |
As of Jun 30 2024, Champions Oncology's largest institutional buyer is VANGUARD GROUP INC. The company purchased 221.40K stocks of CSBR, valued at $1.59M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ESSEX INVESTMENT MANAGEMENT CO LLC | - | - | - | -77,200 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.30% | - | 40,463 | -2,226 | -5.21% | 209,193,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.90% | 0.00% | 122,591 | -2,100 | -1.68% | 633,795 | Jun 30, 2024 |
| UBS GROUP AG | 0.00% | - | 379 | -728 | -65.76% | 1,959 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.19% | - | 25,273 | -553 | -2.14% | 130,661 | Jun 30, 2024 |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT, INC. | 0.09% | 0.00% | 12,000 | -380 | -3.07% | 62,040 | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | 0.08% | 0.00% | 10,942 | -250 | -2.23% | 56,573 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -47 | -100.00% | - | Jun 30, 2024 |
| BATTERY MANAGEMENT CORP. | 17.81% | 3.29% | 2,421,673 | - | - | 12,520,049 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 12.61% | 0.67% | 1,713,720 | - | - | 8,859,932 | Jun 30, 2024 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 5.04% | 0.06% | 684,628 | - | - | 3,539,527 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.23% | 0.00% | 30,697 | - | - | 157,000 | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.25% | 0.00% | 34,308 | - | - | 178,000 | Jun 30, 2024 |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 0.09% | 0.00% | 12,252 | - | - | 63,000 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.20% | - | 26,749 | - | - | 138,293 | Jun 30, 2024 |
| STATE STREET CORP | 0.20% | - | 26,553 | - | - | 137,279,000 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 11 | - | - | 57 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.51% | 0.00% | 69,304 | 3 | 0.00% | 358,302 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.00% | - | 133 | 133 | 100.00% | 1,000 | Jun 30, 2024 |
| BLACKROCK INC. | 0.85% | - | 116,072 | 389 | 0.34% | 600,093 | Jun 30, 2024 |
As of Jun 30 2024, Champions Oncology's biggest institutional seller is ESSEX INVESTMENT MANAGEMENT CO LLC. The company sold -77.20K shares of CSBR, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ESSEX INVESTMENT MANAGEMENT CO LLC | - | - | - | -77,200 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -47 | -100.00% | - | Jun 30, 2024 |
Champions Oncology's largest sold out institutional shareholder by shares sold is ESSEX INVESTMENT MANAGEMENT CO LLC, sold -77.20K shares, valued at -, as of undefined.
Champions Oncology Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| OBERWEIS FUNDS | 0.05% | 54,333 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.04% | 20,599 | - | - | Apr 30, 2021 |
| AMG FUNDS III | 0.02% | 113,355 | - | - | Mar 28, 2024 |
| AMG Funds I | 0.01% | 17,649 | - | - | Jan 31, 2024 |
| FORUM FUNDS II | 0.01% | 7,500 | - | - | Jan 31, 2024 |
| Federated Hermes MDT Series | 0.00% | 5,894 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 1,345 | - | - | Mar 31, 2024 |
| SSGA FUNDS | 0.00% | 944 | - | - | Feb 29, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 10,748 | - | - | Mar 31, 2024 |
| World Funds Trust | 0.00% | 20,000 | - | - | Jan 31, 2024 |
| GPS Funds I | 0.00% | 2,866 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,068 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 56,579 | 540 | 0.96% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 637 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 6,286 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 83,511 | -55,504 | -39.93% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 6,854 | - | - | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 6,377 | - | - | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 6,756 | - | - | Mar 28, 2024 |
| LoCorr Investment Trust | 0.00% | 1,100 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 38,199 | 5,130 | 15.51% | Jan 31, 2024 |
| PGIM ETF TRUST | 0.00% | 2,327 | - | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 1,100 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 146 | - | - | Mar 31, 2024 |
| EMPOWER FUNDS, INC. | 0.00% | 14,200 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 48,414 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 3,213 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 20,771 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 2,031 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 1,218 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 1,028 | - | - | Jan 31, 2024 |
| Advisors' Inner Circle Fund II | 0.00% | 6,000 | - | - | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 5,806 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 503 | - | - | Feb 29, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 1,410 | - | - | Dec 31, 2023 |
| TIAA-CREF FUNDS | 0.00% | 11,574 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 58 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 592 | - | - | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 732 | - | - | Mar 31, 2024 |
| AMERICAN BEACON FUNDS | 0.00% | 4,057 | - | - | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 1,269 | 15 | 1.20% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 14,914 | -401 | -2.62% | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 863 | - | - | Dec 31, 2023 |
| PACIFIC SELECT FUND | 0.00% | 2,962 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 2,653 | - | - | Mar 31, 2024 |
| Franklin Templeton ETF Trust | 0.00% | 80 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 101 | - | - | Jan 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 1,320 | - | - | Feb 29, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 870 | - | - | Mar 31, 2024 |
| AIM INVESTMENT FUNDS (INVESCO INVESTMENT FUNDS) | 0.00% | 2,050 | - | - | Jan 31, 2024 |
Champions Oncology's largest mutual fund holder by % of total assets is "OBERWEIS FUNDS", owning 54.33K shares, compromising 0.05% of its total assets.
Champions Oncology Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 9 | -65.38% |
| 31 Mar, 24 | 26 | -3.70% |
| 31 Dec, 23 | 27 | -12.90% |
| 30 Sep, 23 | 31 | -3.13% |
| 30 Jun, 23 | 32 | 6.67% |
| 31 Mar, 23 | 30 | 7.14% |
| 31 Dec, 22 | 28 | -6.67% |
| 30 Sep, 22 | 30 | - |
| 30 Jun, 22 | 30 | 3.45% |
| 31 Mar, 22 | 29 | 3.57% |
| 31 Dec, 21 | 28 | -12.50% |
| 30 Sep, 21 | 32 | -11.11% |
| 30 Jun, 21 | 36 | -18.18% |
| 31 Mar, 21 | 44 | -4.35% |
| 31 Dec, 20 | 46 | 2.22% |
| 30 Sep, 20 | 45 | - |
| 30 Jun, 20 | 45 | 50.00% |
| 31 Mar, 20 | 30 | -3.23% |
| 31 Dec, 19 | 31 | - |
| 30 Sep, 19 | 31 | -16.22% |
| 30 Jun, 19 | 37 | - |
| 31 Mar, 19 | 37 | -17.78% |
| 31 Dec, 18 | 45 | 25.00% |
| 30 Sep, 18 | 36 | 111.76% |
| 30 Jun, 18 | 17 | 30.77% |
| 31 Mar, 18 | 13 | - |
| 31 Dec, 17 | 13 | -13.33% |
| 30 Sep, 17 | 15 | - |
| 30 Jun, 17 | 15 | -6.25% |
| 31 Mar, 17 | 16 | 60.00% |
| 31 Dec, 16 | 10 | -41.18% |
| 30 Sep, 16 | 17 | 41.67% |
| 30 Jun, 16 | 12 | 33.33% |
| 31 Mar, 16 | 9 | -25.00% |
| 31 Dec, 15 | 12 | 33.33% |
| 30 Sep, 15 | 9 | - |
As of 30 Jun 24, 9 institutions are holding Champions Oncology's shares, representing a decrease of -65.38% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 955,018 | -83.05% |
| 31 Mar, 24 | 5,633,547 | 0.38% |
| 31 Dec, 23 | 5,612,282 | -2.20% |
| 30 Sep, 23 | 5,738,643 | -0.98% |
| 30 Jun, 23 | 5,795,391 | -0.76% |
| 31 Mar, 23 | 5,840,016 | -2.35% |
| 31 Dec, 22 | 5,980,432 | -3.77% |
| 30 Sep, 22 | 6,214,655 | -0.10% |
| 30 Jun, 22 | 6,220,927 | 0.85% |
| 31 Mar, 22 | 6,168,551 | -0.17% |
| 31 Dec, 21 | 6,178,793 | -1.14% |
| 30 Sep, 21 | 6,250,024 | -5.69% |
| 30 Jun, 21 | 6,627,265 | -7.97% |
| 31 Mar, 21 | 7,201,226 | 0.98% |
| 31 Dec, 20 | 7,131,440 | 0.66% |
| 30 Sep, 20 | 7,084,971 | 1.65% |
| 30 Jun, 20 | 6,969,819 | 7.77% |
| 31 Mar, 20 | 6,467,200 | 12.73% |
| 31 Dec, 19 | 5,737,016 | 0.09% |
| 30 Sep, 19 | 5,731,716 | -6.13% |
| 30 Jun, 19 | 6,106,126 | -0.48% |
| 31 Mar, 19 | 6,135,684 | 1.59% |
| 31 Dec, 18 | 6,039,677 | 5.21% |
| 30 Sep, 18 | 5,740,465 | 33.91% |
| 30 Jun, 18 | 4,286,964 | 0.13% |
| 31 Mar, 18 | 4,281,229 | 2.84% |
| 31 Dec, 17 | 4,163,006 | 0.07% |
| 30 Sep, 17 | 4,160,023 | -0.30% |
| 30 Jun, 17 | 4,172,600 | 0.80% |
| 31 Mar, 17 | 4,139,554 | -4.22% |
| 31 Dec, 16 | 4,321,802 | -15.75% |
| 30 Sep, 16 | 5,129,977 | -4.48% |
| 30 Jun, 16 | 5,370,595 | 4.45% |
| 31 Mar, 16 | 5,141,667 | 0.04% |
| 31 Dec, 15 | 5,139,720 | 4.94% |
| 30 Sep, 15 | 4,897,826 | - |
Champions Oncology (CSBR) has 955.02K shares outstanding as of 30 Jun 24, down -83.05% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 7.03% | 0.41% |
| 31 Mar, 24 | 41.44% | 2.40% |
| 31 Dec, 23 | 41.58% | 2.30% |
| 30 Sep, 23 | 42.49% | 2.33% |
| 30 Jun, 23 | 42.74% | 2.30% |
| 31 Mar, 23 | 43.07% | 2.21% |
| 31 Dec, 22 | 44.11% | 2.09% |
| 30 Sep, 22 | 45.94% | 2.17% |
| 30 Jun, 22 | 46.00% | 2.11% |
| 31 Mar, 22 | 46.74% | 2.23% |
| 31 Dec, 21 | 45.77% | 2.11% |
| 30 Sep, 21 | 46.54% | 1.90% |
| 30 Jun, 21 | 49.45% | 1.71% |
| 31 Mar, 21 | 53.73% | 1.89% |
| 31 Dec, 20 | 53.33% | 1.81% |
| 30 Sep, 20 | 54.23% | 1.81% |
| 30 Jun, 20 | 54.76% | 2.01% |
| 31 Mar, 20 | 52.19% | 2.19% |
| 31 Dec, 19 | 48.81% | 2.01% |
| 30 Sep, 19 | 49.33% | 1.79% |
| 30 Jun, 19 | 52.55% | 1.80% |
| 31 Mar, 19 | 54.11% | 1.96% |
| 31 Dec, 18 | 52.48% | 2.10% |
| 30 Sep, 18 | 50.03% | 3.31% |
| 30 Jun, 18 | 38.87% | 2.57% |
| 31 Mar, 18 | 38.91% | 2.72% |
| 31 Dec, 17 | 37.84% | 2.64% |
| 30 Sep, 17 | 37.86% | 2.62% |
| 30 Jun, 17 | 37.99% | 2.67% |
| 31 Mar, 17 | 37.69% | 2.43% |
| 31 Dec, 16 | 39.39% | 1.80% |
| 30 Sep, 16 | 46.77% | 1.95% |
| 30 Jun, 16 | 48.97% | 1.40% |
| 31 Mar, 16 | 59.07% | 1.69% |
| 31 Dec, 15 | 59.06% | 1.86% |
| 30 Sep, 15 | 56.34% | - |
As of 30 Jun 24, Champions Oncology is held by 7.03% institutional shareholders, representing a 0.41% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 2 | -81.82% |
| 31 Mar, 24 | 11 | 57.14% |
| 31 Dec, 23 | 7 | - |
| 30 Sep, 23 | 7 | -36.36% |
| 30 Jun, 23 | 11 | - |
| 31 Mar, 23 | 11 | 22.22% |
| 31 Dec, 22 | 9 | - |
| 30 Sep, 22 | 9 | 28.57% |
| 30 Jun, 22 | 7 | -22.22% |
| 31 Mar, 22 | 9 | -10.00% |
| 31 Dec, 21 | 10 | 11.11% |
| 30 Sep, 21 | 9 | -25.00% |
| 30 Jun, 21 | 12 | -40.00% |
| 31 Mar, 21 | 20 | 17.65% |
| 31 Dec, 20 | 17 | 21.43% |
| 30 Sep, 20 | 14 | -58.82% |
| 30 Jun, 20 | 34 | 183.33% |
| 31 Mar, 20 | 12 | -14.29% |
| 31 Dec, 19 | 14 | 75.00% |
| 30 Sep, 19 | 8 | -46.67% |
| 30 Jun, 19 | 15 | -11.76% |
| 31 Mar, 19 | 17 | -41.38% |
| 31 Dec, 18 | 29 | - |
| 30 Sep, 18 | 29 | 163.64% |
| 30 Jun, 18 | 11 | 175.00% |
| 31 Mar, 18 | 4 | - |
| 31 Dec, 17 | 4 | -33.33% |
| 30 Sep, 17 | 6 | 20.00% |
| 30 Jun, 17 | 5 | -44.44% |
| 31 Mar, 17 | 9 | 350.00% |
| 31 Dec, 16 | 2 | -75.00% |
| 30 Sep, 16 | 8 | 100.00% |
| 30 Jun, 16 | 4 | 300.00% |
| 31 Mar, 16 | 1 | -87.50% |
| 31 Dec, 15 | 8 | -11.11% |
| 30 Sep, 15 | 9 | - |
2 institutional shareholders have increased their position in CSBR stock as of 30 Jun 24 compared to 11 in the previous quarter (a -81.82% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 2 | -75.00% |
| 31 Mar, 24 | 8 | -11.11% |
| 31 Dec, 23 | 9 | -10.00% |
| 30 Sep, 23 | 10 | 25.00% |
| 30 Jun, 23 | 8 | 100.00% |
| 31 Mar, 23 | 4 | -50.00% |
| 31 Dec, 22 | 8 | - |
| 30 Sep, 22 | 8 | 33.33% |
| 30 Jun, 22 | 6 | -14.29% |
| 31 Mar, 22 | 7 | 16.67% |
| 31 Dec, 21 | 6 | -62.50% |
| 30 Sep, 21 | 16 | 6.67% |
| 30 Jun, 21 | 15 | - |
| 31 Mar, 21 | 15 | -21.05% |
| 31 Dec, 20 | 19 | 5.56% |
| 30 Sep, 20 | 18 | 260.00% |
| 30 Jun, 20 | 5 | -50.00% |
| 31 Mar, 20 | 10 | - |
| 31 Dec, 19 | 10 | -9.09% |
| 30 Sep, 19 | 11 | 10.00% |
| 30 Jun, 19 | 10 | -9.09% |
| 31 Mar, 19 | 11 | - |
| 31 Dec, 18 | 11 | 266.67% |
| 30 Sep, 18 | 3 | - |
| 30 Jun, 18 | - | -100.00% |
| 31 Mar, 18 | 4 | 33.33% |
| 31 Dec, 17 | 3 | 50.00% |
| 30 Sep, 17 | 2 | - |
| 30 Jun, 17 | - | -100.00% |
| 31 Mar, 17 | 4 | - |
| 31 Dec, 16 | 4 | 33.33% |
| 30 Sep, 16 | 3 | 50.00% |
| 30 Jun, 16 | 2 | - |
| 31 Mar, 16 | 2 | - |
| 31 Dec, 15 | - | - |
| 30 Sep, 15 | - | - |
2 institutional shareholders have reduced their position in CSBR stock as of 30 Jun 24 compared to 8 in the previous quarter (a -75.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 9 | -65.38% | 955,018 | -83.05% | 7.03% | 0.41% | 2 | -81.82% | 2 | -75.00% |
| 31 Mar, 24 | 26 | -3.70% | 5,633,547 | 0.38% | 41.44% | 2.40% | 11 | 57.14% | 8 | -11.11% |
| 31 Dec, 23 | 27 | -12.90% | 5,612,282 | -2.20% | 41.58% | 2.30% | 7 | - | 9 | -10.00% |
| 30 Sep, 23 | 31 | -3.13% | 5,738,643 | -0.98% | 42.49% | 2.33% | 7 | -36.36% | 10 | 25.00% |
| 30 Jun, 23 | 32 | 6.67% | 5,795,391 | -0.76% | 42.74% | 2.30% | 11 | - | 8 | 100.00% |
| 31 Mar, 23 | 30 | 7.14% | 5,840,016 | -2.35% | 43.07% | 2.21% | 11 | 22.22% | 4 | -50.00% |
| 31 Dec, 22 | 28 | -6.67% | 5,980,432 | -3.77% | 44.11% | 2.09% | 9 | - | 8 | - |
| 30 Sep, 22 | 30 | - | 6,214,655 | -0.10% | 45.94% | 2.17% | 9 | 28.57% | 8 | 33.33% |
| 30 Jun, 22 | 30 | 3.45% | 6,220,927 | 0.85% | 46.00% | 2.11% | 7 | -22.22% | 6 | -14.29% |
| 31 Mar, 22 | 29 | 3.57% | 6,168,551 | -0.17% | 46.74% | 2.23% | 9 | -10.00% | 7 | 16.67% |
| 31 Dec, 21 | 28 | -12.50% | 6,178,793 | -1.14% | 45.77% | 2.11% | 10 | 11.11% | 6 | -62.50% |
| 30 Sep, 21 | 32 | -11.11% | 6,250,024 | -5.69% | 46.54% | 1.90% | 9 | -25.00% | 16 | 6.67% |
| 30 Jun, 21 | 36 | -18.18% | 6,627,265 | -7.97% | 49.45% | 1.71% | 12 | -40.00% | 15 | - |
| 31 Mar, 21 | 44 | -4.35% | 7,201,226 | 0.98% | 53.73% | 1.89% | 20 | 17.65% | 15 | -21.05% |
| 31 Dec, 20 | 46 | 2.22% | 7,131,440 | 0.66% | 53.33% | 1.81% | 17 | 21.43% | 19 | 5.56% |
| 30 Sep, 20 | 45 | - | 7,084,971 | 1.65% | 54.23% | 1.81% | 14 | -58.82% | 18 | 260.00% |
| 30 Jun, 20 | 45 | 50.00% | 6,969,819 | 7.77% | 54.76% | 2.01% | 34 | 183.33% | 5 | -50.00% |
| 31 Mar, 20 | 30 | -3.23% | 6,467,200 | 12.73% | 52.19% | 2.19% | 12 | -14.29% | 10 | - |
| 31 Dec, 19 | 31 | - | 5,737,016 | 0.09% | 48.81% | 2.01% | 14 | 75.00% | 10 | -9.09% |
| 30 Sep, 19 | 31 | -16.22% | 5,731,716 | -6.13% | 49.33% | 1.79% | 8 | -46.67% | 11 | 10.00% |
| 30 Jun, 19 | 37 | - | 6,106,126 | -0.48% | 52.55% | 1.80% | 15 | -11.76% | 10 | -9.09% |
| 31 Mar, 19 | 37 | -17.78% | 6,135,684 | 1.59% | 54.11% | 1.96% | 17 | -41.38% | 11 | - |
| 31 Dec, 18 | 45 | 25.00% | 6,039,677 | 5.21% | 52.48% | 2.10% | 29 | - | 11 | 266.67% |
| 30 Sep, 18 | 36 | 111.76% | 5,740,465 | 33.91% | 50.03% | 3.31% | 29 | 163.64% | 3 | - |
| 30 Jun, 18 | 17 | 30.77% | 4,286,964 | 0.13% | 38.87% | 2.57% | 11 | 175.00% | - | -100.00% |
| 31 Mar, 18 | 13 | - | 4,281,229 | 2.84% | 38.91% | 2.72% | 4 | - | 4 | 33.33% |
| 31 Dec, 17 | 13 | -13.33% | 4,163,006 | 0.07% | 37.84% | 2.64% | 4 | -33.33% | 3 | 50.00% |
| 30 Sep, 17 | 15 | - | 4,160,023 | -0.30% | 37.86% | 2.62% | 6 | 20.00% | 2 | - |
| 30 Jun, 17 | 15 | -6.25% | 4,172,600 | 0.80% | 37.99% | 2.67% | 5 | -44.44% | - | -100.00% |
| 31 Mar, 17 | 16 | 60.00% | 4,139,554 | -4.22% | 37.69% | 2.43% | 9 | 350.00% | 4 | - |
| 31 Dec, 16 | 10 | -41.18% | 4,321,802 | -15.75% | 39.39% | 1.80% | 2 | -75.00% | 4 | 33.33% |
| 30 Sep, 16 | 17 | 41.67% | 5,129,977 | -4.48% | 46.77% | 1.95% | 8 | 100.00% | 3 | 50.00% |
| 30 Jun, 16 | 12 | 33.33% | 5,370,595 | 4.45% | 48.97% | 1.40% | 4 | 300.00% | 2 | - |
| 31 Mar, 16 | 9 | -25.00% | 5,141,667 | 0.04% | 59.07% | 1.69% | 1 | -87.50% | 2 | - |
| 31 Dec, 15 | 12 | 33.33% | 5,139,720 | 4.94% | 59.06% | 1.86% | 8 | -11.11% | - | - |
| 30 Sep, 15 | 9 | - | 4,897,826 | - | 56.34% | - | 9 | - | - | - |
Champions Oncology Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Champions Oncology's stock was made by ACKERMAN JOEL on Jan 05 2024, selling 14,552 shares at $2.10 per share (valued at $30.56K). The last insider buy of CSBR was made by Mendelson Daniel Newman on Jan 16 2024, buying 1,000 shares at $6.50 per share (worth $6.50K).
Champions Oncology Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 7 | - | - |
| Q4 2023 | 15 | 1 | 1500.00% |
| Q3 2023 | 8 | - | - |
| Q1 2023 | 1 | - | - |
| Q4 2022 | 10 | 5 | 200.00% |
| Q4 2021 | 9 | 1 | 900.00% |
| Q1 2021 | 5 | 5 | 100.00% |
| Q4 2020 | 8 | 4 | 200.00% |
| Q1 2020 | 18 | 13 | 138.46% |
| Q4 2019 | 8 | 1 | 800.00% |
| Q1 2019 | 5 | 1 | 500.00% |
| Q4 2018 | 8 | 5 | 160.00% |
| Q3 2018 | - | 1 | - |
| Q1 2018 | 5 | - | - |
| Q4 2017 | 4 | - | - |
| Q1 2017 | 1 | - | - |
| Q4 2016 | 36 | - | - |
| Q3 2016 | 25 | 8 | 312.50% |
| Q2 2016 | - | 1 | - |
| Q4 2015 | 6 | - | - |
7 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Champions Oncology's insiders, as of Q1 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 7 | - | - |
| Q4 2023 | 9 | - | - |
| Q3 2023 | 8 | - | - |
| Q1 2023 | 1 | - | - |
| Q4 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | 1 | - |
| Q1 2020 | 7 | 2 | 350.00% |
| Q4 2019 | - | - | - |
| Q1 2019 | - | - | - |
| Q4 2018 | 1 | 2 | 50.00% |
| Q3 2018 | - | 1 | - |
| Q1 2018 | 5 | - | - |
| Q4 2017 | - | - | - |
| Q1 2017 | - | - | - |
| Q4 2016 | 29 | - | - |
| Q3 2016 | 7 | - | - |
| Q2 2016 | - | - | - |
| Q4 2015 | - | - | - |
As of Q1 2024, Insider owners conducted 7 open market buy trades and 0 open market sell trades of Champions Oncology's stocks.
Champions Oncology Peer Ownership
| Ticker | Company |
|---|---|
| CYT | Cyteir Therapeutics, Inc. |
| IPSC | Century Therapeutics, Inc. |
| AVTE | Aerovate Therapeutics, Inc. |
| ACRV | Acrivon Therapeutics, Inc. Common Stock |
| ANTX | AN2 Therapeutics, Inc. |
| HCWB | HCW Biologics Inc. |
| MNOV | MediciNova, Inc. |
| RZLT | Rezolute, Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| ADAG | Adagene Inc. |
| MOLN | Molecular Partners AG |
| PRDS | Pardes Biosciences, Inc. |
| STTK | Shattuck Labs, Inc. |
| ELYM | Eliem Therapeutics, Inc. |
CSBR Ownership FAQ
Who Owns Champions Oncology?
Champions Oncology is owned by institutional shareholders (7.03%), insiders (25.55%), and public (67.42%). The largest institutional shareholder of Champions Oncology is BATTERY MANAGEMENT CORP. (17.81% of total shares) and the top mutual fund owner is OBERWEIS FUNDS (0.05% of total shares).
Who are the major institutional shareholders of Champions Oncology?
Champions Oncology's major institutional shareholders are BATTERY MANAGEMENT CORP., NEA MANAGEMENT COMPANY, LLC, TOCQUEVILLE ASSET MANAGEMENT L.P., VANGUARD GROUP INC, and RENAISSANCE TECHNOLOGIES LLC. The top five shareholders own together 38.62% of the company's share outstanding.
How many Champions Oncology shareholders are there?
As of Jun 2024, there are 9 institutional shareholders of Champions Oncology.
What percentage of Champions Oncology is owned by BATTERY MANAGEMENT CORP?
BATTERY MANAGEMENT CORP owns 2.42M shares of Champions Oncology, representing 17.81% of the company's total shares outstanding, valued at $12.52M (as of Jun 2024).
What percentage of Champions Oncology is owned by NEA MANAGEMENT COMPANY, LLC?
As of Jun 2024, NEA MANAGEMENT COMPANY, LLC holds 1.71M shares of Champions Oncology (CSBR), compromising 12.61% of the company, valued at $8.86M.
What percentage of Champions Oncology is owned by TOCQUEVILLE ASSET MANAGEMENT L.P?
TOCQUEVILLE ASSET MANAGEMENT L.P is the third largest holder of Champions Oncology. The company owns 684.63K of the company's shares outstanding (worth $3.54M).